Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | FABP1 | P07148 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17456550 | 0.98 | SLC22A6 (0.44) | SLC22A6ALDH1A1LMNAMEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL28878776 | 0.98 | SLC22A6 (0.44) | SLC22A6ALDH1A1LMNAMEN1KMT2A | |
| Phosphoric Acid SCHEMBL28732281 | 0.92 | SLC22A6 (0.41) | SLC22A6ALDH1A1LMNAMEN1KMT2A | |
| Potassium Ion SCHEMBL28132987 | 0.91 | SLC22A6 (0.40) | SLC22A6ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL514247 | 0.84 | SLC22A6 (0.53) | SLC22A6ALDH1A1LMNAFABP1TSHR | |
| SCHEMBL4120032 | 0.83 | MAPT (0.47) | SLC22A6ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL29468655 | 0.82 | ALDH1A1 (0.46) | ALDH1A1LMNAMEN1KMT2AESR1 | |
| SCHEMBL777548 | 0.82 | ALDH1A1 (0.46) | ALDH1A1LMNAMEN1KMT2AESR1 | |
| Hydrogen Sulfide SCHEMBL3797182 | 0.82 | MAPT (0.46) | SLC22A6ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL17157291 | 0.82 | ALDH1A1 (0.48) | SLC22A6ALDH1A1LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133394-A1 | METABOLIC FINGERPRINTING OF SALIVA SAMPLES USING NMR | MAVEN HEALTH GMBH (CH) | 2025-06-26 | — | — | WO | claimed |
| US-20240393304-A1 | METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRIGONELLINE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF | NESTLE SA (CH) | 2024-11-28 | — | — | US | claimed |
| EP-4409295-A1 | METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRIGONELLINE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF | Société des Produits Nestlé S.A. (CH) | 2024-08-07 | — | — | EP | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| CN-117126189-A | 3-thio-3- (trimethylsilyl) -1-ketone compound, preparation method and application thereof | 南京工业大学 | 2023-11-28 | — | — | CN | claimed |
| EP-4188075-A1 | NUTRIENT LOSS REDUCTION METHOD, USES AND PRODUCTS | PGG Wrightson Seeds Limited (NZ) | 2023-06-07 | — | — | EP | claimed |
| WO-2023052261-A1 | METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRIGONELLINE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF. | Société des Produits Nestlé S.A. (CH) | 2023-04-06 | — | — | WO | claimed |
| WO-2023004055-A1 | METABOLIC AND INFLAMMATORY MARKERS FOR CAR-T CELL THERAPY | THE CLEVELAND CLINIC FOUNDATION (US) | 2023-01-26 | — | — | WO | claimed |
| WO-2022025774-A1 | NUTRIENT LOSS REDUCTION METHOD, USES AND PRODUCTS | PGG WRIGHTSON SEEDS LIMITED (NZ) | 2022-02-03 | — | — | WO | claimed |
| WO-2021207822-A1 | DETECTION, TREATMENT, AND MONITORING OF MICROBIOME-DEPENDANT PROTEIN FERMENTATION METABOLITES | MCPHARMA BIOTECH INC. (CA) | 2021-10-21 | — | — | WO | claimed |
| CN-105209909-B | Biomarkers associated with renal function and methods of use thereof | 梅塔博隆股份有限公司 | 2019-06-07 | — | — | CN | claimed |
| WO-2018112198-A1 | SWEAT SENSING DEVICE KIDNEY BIOMARKER MEASUREMENT | ECCRINE SYSTEMS, INC. (US) | 2018-06-21 | — | — | WO | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2016115496-A1 | METABOLITE BIOMARKERS PREDICTIVE OF RENAL DISEASE IN DIABETIC PATIENTS | JOSLIN DIABETES CENTER (US) | 2016-07-21 | — | — | WO | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| WO-2011010103-A1 | METHODS AND USES | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-01-27 | — | — | WO | claimed |
| CN-1799162-A | Lithium secondary battery | MITSUBISHI CHEM CORP (JP) | 2006-07-05 | — | — | CN | claimed |
| US-20040110068-A1 | Lithium secondary cell | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-06-10 | — | — | US | claimed |
| EP-1406338-A1 | LITHIUM SECONDARY CELL | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-07 | — | — | EP | claimed |
| EP-0078349-A1 | Antibiotic novel dianemycin derivative | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1983-05-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240393304-A1 | METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRIGONELLINE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF | GRM4, TLR4, HTR4 | SLC22A6 318/4885ALDH1A1 1194/4885LMNA 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.